Updated December 30, 2025
The original link didn't age well.
You might still be interested in:
FDA - Human Drug Compounding:
https://www.fda.gov/drugs/guidance-compliance-regulatory-information/human-drug-compounding
--- the original post follows below ---
"The Senate was expected to take up a bill designed to secure the drug supply chain and establish a list of "do not compound" medications, but left for recess Friday without voting on it.
The bill, S. 959, the Pharmaceutical Quality, Security and Accountability Act, had received some support from groups like the National Community Pharmacists Association, which supported the bill's goal of enhancing security, but expressed reservations about the compounding provision."
Return Home: The Designated Representative and Exemptee Blog
For Designated Representative license applicants - Training programs, courses, classes, seminars:
California (earn a training affidavit):- CA Designated Representative Wholesaler Training - Available around-the-clock 24 x 7
- CA Designated Representative 3PL Training
- CA Designated Representative Reverse Distributor Training
- The Designated Representative Institute